Cargando…

Evolution of anti-modified protein antibody responses can be driven by consecutive exposure to different post-translational modifications

BACKGROUND: Besides anti-citrullinated protein antibodies (ACPA), rheumatoid arthritis patients (RA) often display autoantibody reactivities against other post-translationally modified (PTM) proteins, more specifically carbamylated and acetylated proteins. Immunizing mice with one particular PTM res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Volkov, M., Kampstra, A. S. B., van Schie, K. A., Kawakami, A., Tamai, M., Kawashiri, S., Maeda, T., Huizinga, T. W. J., Toes, R. E. M., van der Woude, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653599/ https://www.ncbi.nlm.nih.gov/pubmed/34876234 http://dx.doi.org/10.1186/s13075-021-02687-5

Ejemplares similares

The increased ability to present citrullinated peptides is not unique to HLA-SE molecules: arginine-to-citrulline conversion also enhances peptide affinity for HLA-DQ molecules
por: Kampstra, Arieke S. B., et al.
Publicado: (2016)

Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiology
por: Volkov, Mikhail, et al.
Publicado: (2019)

HLA class II and rheumatoid arthritis: the bumpy road of revelation
por: Kampstra, Arieke S.B., et al.
Publicado: (2017)

IgG Anti–Citrullinated Protein Antibody Variable Domain Glycosylation Increases Before the Onset of Rheumatoid Arthritis and Stabilizes Thereafter: A Cross‐Sectional Study Encompassing ~1,500 Samples
por: Kissel, Theresa, et al.
Publicado: (2022)

Evolution and functional cross‐talk of protein post‐translational modifications
por: Beltrao, Pedro, et al.
Publicado: (2013)

In rheumatoid arthritis patients, total IgA1 and IgA2 levels are elevated: implications for the mucosal origin hypothesis
por: Derksen, Veerle F A M, et al.
Publicado: (2022)

Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load
por: Reijm, Sanne, et al.
Publicado: (2021)

Absence of Epstein-Barr virus DNA in anti-citrullinated protein antibody-expressing B cells of patients with rheumatoid arthritis
por: Kroos, Sanne, et al.
Publicado: (2022)

Ligandomes obtained from different HLA-class II-molecules are homologous for N- and C-terminal residues outside the peptide-binding cleft
por: Kampstra, Arieke S.B., et al.
Publicado: (2019)

Modification of episodic memories by novel learning: a failed replication study
por: van Schie, Kevin, et al.
Publicado: (2017)

The role of autoantibodies in the pathophysiology of rheumatoid arthritis
por: Derksen, V. F. A. M., et al.
Publicado: (2017)

The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients
por: van Delft, Myrthe A. M., et al.
Publicado: (2017)

Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series
por: van Schie, P., et al.
Publicado: (2023)

Autoimmune Responses in the Rheumatoid Synovium
por: Toes, Rene E. M, et al.
Publicado: (2009)

Toward Understanding the Essence of Post-Translational Modifications for the Mycobacterium tuberculosis Immunoproteome
por: van Els, Cécile A. C. M., et al.
Publicado: (2014)

Glycosylation—The Most Diverse Post-Translational Modification
por: Staudacher, Erika, et al.
Publicado: (2022)

Genetics of rheumatoid arthritis: what have we learned?
por: Bax, Marieke, et al.
Publicado: (2011)

Autoantibodies to GPI are predominantly present in extra-articular complications of human rheumatoid arthritis
por: van Gaalen, FA, et al.
Publicado: (2003)

Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations
por: Monahan, Rory C, et al.
Publicado: (2022)

Convergent evolution of a modified, acetate-driven TCA cycle in bacteria
por: Kwong, Waldan K., et al.
Publicado: (2017)

An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting
por: van Heemst, Jurgen, et al.
Publicado: (2015)

Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populations
por: de Moel, Emma C., et al.
Publicado: (2023)

Human cartilage glycoprotein-39 directed T-cell responses in health and arthritic diseases
por: Toes, R, et al.
Publicado: (2003)

Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activation
por: Kissel, Theresa, et al.
Publicado: (2022)

Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association
por: van den Beukel, Michelle D, et al.
Publicado: (2023)

Nine Post-translational Modifications during the Biosynthesis of Cinnamycin
por: Ökesli, Ayşe, et al.
Publicado: (2011)

Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes
por: de Moel, Emma C., et al.
Publicado: (2018)

In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response
por: de Moel, Emma C., et al.
Publicado: (2019)

Phase variation controls expression of Salmonella lipopolysaccharide modification genes by a DNA methylation-dependent mechanism
por: Broadbent, S E, et al.
Publicado: (2010)

Post-translational modifications in embryonic cell cycle
por: Van der Laan, Siem, et al.
Publicado: (2014)

Host–Receptor Post-Translational Modifications Refine Staphylococcal Leukocidin Cytotoxicity
por: Tromp, Angelino T., et al.
Publicado: (2020)

Speed Matters: Relationship between Speed of Eye Movements and Modification of Aversive Autobiographical Memories
por: van Veen, Suzanne Chantal, et al.
Publicado: (2015)

Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010
por: Ichinose, Kunihiro, et al.
Publicado: (2018)

Fibroblast-like synoviocytes obtained from different joints at different times from one patient show similar invasiveness in vitro
por: Tolboom, TCA, et al.
Publicado: (2003)

PTPN22 as a rheumatoid arthritis susceptibility but not severity gene
por: Wesoly, J, et al.
Publicado: (2005)

Unitary Evolution and Elements of Reality in Consecutive Quantum Measurements
por: Sokolovski, Dmitri
Publicado: (2022)

Proteomic characterization of novel histone post-translational modifications
por: Arnaudo, Anna M, et al.
Publicado: (2013)

Discovery of Post-Translational Modifications in Emiliania huxleyi
por: Duong, Van-An, et al.
Publicado: (2021)

Analysis of IL-10 gene variants in rheumatoid arthritis
por: Huizinga, T, et al.
Publicado: (2003)

The invasiveness of fibroblast-like synoviocytes is of relevance for the rate of joint destruction in patients with rheumatoid arthritis and is a patient characteristic
por: Tolboom, TCA, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_mqcqvbajtp97s3hmrus2tms9bd